Table 2 Prevalence of CTC graded urinary retention at each follow-up
From: Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer
| Â | 1 Mon | 3 Mon | 6 Mon | 9 Mon | 12 Mon | 18 Mon | 24 Mon |
|---|---|---|---|---|---|---|---|
Grade 0 | 41.7% | 57.7% | 55.0% | 58.7% | 56.2% | 54.5% | 55.4% |
Grade 1 | 21.6% | 16.6% | 20.7% | 19.0% | 18.7% | 19.3% | 21.2% |
Grade 2 | 36.7% | 25.7% | 23.9% | 21.9% | 25.1% | 25.8% | 23.0% |
Grade 3 | 0.0% | 0.0% | 0.4% | 0.4% | 0.0% | 0.4% | 0.5% |